Abstract
Optimal Use of Biomarkers in Oncology.
Highlights
In oncological routine, the correlation of biomarker levels with the clinical status and medical imaging methods is of great significance
Studying gene expressions and molecular pathways may lead to the discovery of new prognostic biomarkers, markers of early diagnostics, or molecular targets for therapy
BAFF/BAFF-R signaling may be a promising target of future therapy in B-cell derived leukemias and lymphomas
Summary
The correlation of biomarker levels with the clinical status and medical imaging methods is of great significance. J. Wolfe,3 Vivian Barak,4 and Tomas Zima5 Their use has evolved beyond the research laboratory to more routine clinical use as in diagnosis, monitoring of disease status, and treatment efficacy.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
